About Pro-Biokem
Pro-Biokem is a company based in Khordha (India) founded in 2018 by Baisun Nesha and Mahammad Gulebahar Sheikh. Pro-Biokem has raised $70.12 thousand across 1 funding round from investors including KIIT Technology Business Incubator. Pro-Biokem operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Khordha, India
- Founders Baisun Nesha, Mahammad Gulebahar Sheikh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Pro-Biokem India Private Limited
- Date of Incorporation 01 Mar, 2018
- Jurisdiction Bhubaneswar, Orissa, India
-
Annual Revenue
$9.39 K (USD)0as on Mar 31, 2021
-
Net Profit
-$9.85 K (USD)62as on Mar 31, 2021
-
EBITDA
-$5.72 K (USD)72as on Mar 31, 2021
-
Total Equity Funding
$70.12 K (USD)
in 1 rounds
-
Latest Funding Round
$70.12 K (USD), Seed
Dec 06, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pro-Biokem
Pro-Biokem has successfully raised a total of $70.12K through 1 strategic funding round. The most recent funding activity was a Seed round of $70.12 thousand completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pro-Biokem
Pro-Biokem has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include KIIT Technology Business Incubator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups incubator by KIIT University
|
Locked | Locked | Locked |
Investor details for Pro-Biokem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pro-Biokem
Investment portfolio details for Pro-Biokem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pro-Biokem
Detailed financials for Pro-Biokem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pro-Biokem Comparisons
Peer comparison for Pro-Biokem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pro-Biokem
Pro-Biokem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Pro-Biokem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pro-Biokem
Complete news archive for Pro-Biokem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pro-Biokem
Pro-Biokem was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Pro-Biokem is headquartered in Khordha, India. It is registered at Khordha, Odisha, India.
Pro-Biokem is a funded company, having raised a total of $70.12K across 1 funding round to date.
Annual revenue of Pro-Biokem is $9.39K as on Mar 31, 2021.
Pro-Biokem was founded in 2018 in Khordha, India, focusing on the chemical and biochemical sector. Operations involve the production and distribution of materials including cellulose powder, alpha-cellulose, silica gel, microcrystalline cellulose, and nutrient salts. These products serve applications in plant cell structures, agricultural waste processing, gas and vapor adsorption, chromatography, and food additives. The company maintains a presence in the Indian market for such supplies.
Pro-Biokem's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Pro-Biokem has 1 investor. Key investors include KIIT Technology Business Incubator.
The valuation of Pro-Biokem is $771.94K as of Dec 2019.